An NIH-supported clinical trial of pomalidomide in treating hereditary hemorrhagic telangiectasia stopped early due to ...
A clinical trial has demonstrated that the cancer drug pomalidomide is safe and effective in treating hereditary hemorrhagic ...
Still, the coalition knows that making clinical trials more accessible to underrepresented groups doesn’t necessarily mean that members of those groups will participate in the studies. Hayes noted ...
A grant from the National Institutes of Health will support ongoing research at Wayne State University investigating the consequences environmental factors may have on fertility in males.
A drug approved for treating the blood cancer multiple myeloma may offer a safe and effective way to reduce the risk of severe nosebleeds from a rare but devastating bleeding disorder. Hereditary ...
A clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient ...
News Medical on MSN3d
Clinical trial finds pomalidomide effective for treating rare bleeding disorderA clinical trial supported by the National Institutes of Health (NIH) was stopped early after researchers found sufficient evidence that a drug used to treat bone marrow cancer and Kaposi sarcoma is ...
As part of the U.S. government response to the current mpox outbreak, the National Institutes of Health’s (NIH) National ...
University of Utah Health approached a half-billion dollars ($492.3 million) in research funding in fiscal year 2024.
The New England Journal of Medicine published the trial results, which show that patients with HHT who were administered the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback